Deep Dive - Season 2

Dr. Misha Rosenbach takes us on a deep dive into climate change and its effect on dermatology. From increases in vector-borne diseases to wildfires causing in uptick in atopic dermatitis, climate change affects more than just the environment, but also our health. Dr. Rosenbach explores not only the effects of climate change, but also provides insightful tips on how physicians can help.

Rebecca Madsen, chief consumer officer or UnitedHealthcare, discusses the company’s use of predictive analytics to identify members who may need help with food insecurity, housing and other social determinants of health.

Dr. John Buse discusses treatment of type 2 diabetes on the long-awaited results of a first-of-its-kind study that compared 4 common drugs for type 2 diabetes against each other to evaluate efficacy and safety as an add-on, second-line treatment to control hyperglycemia.

Dr. Mitchell Elkind, the sitting president of the American Heart Association, offers insight into the organization’s recently released scientific statement calling for improved comprehensive post-stroke management, with a particular focus on the crucial role primary care providers can play. Elkind additionally spoke to how this guidance ties into the recent updated secondary prevention guidelines issued in June 2021, and how the a holistic approach to stroke care is vital to good outcomes for patients.

Pharmacy Times interviewed Dr. Clive Ward Able, the president of Clintell and a trained pharmacist and physician who has worked in the pharmacy industry for over 30 years. During this discussion, Dr. Ward Able addresses his research investigating the use of psychedelic compounds to treat obesity, as well as optimize human health.

Martin S. Tallman, MD, a Professor of Medicine at Weill Cornell Medical College and the Chief of the Leukemia Service at Memorial Sloan Kettering Cancer Center, discusses his role as President of the American Society of Hematology, as well as developments and challenges facing the hematologic oncology field.

Dr. Rupa Wong, Rupa Wong, MD, an ophthalmologist practicing at Honolulu Eye Clinic, weighs in on myopia in children, discusses how the pandemic impacted eye health in children, and best practices to maintain optimal eye health as children get ready for the new school year.

Pharmacy Times interviewed Jay Lieberman, MD, a pediatric infectious disease specialist and senior medical director of PRA Health Sciences to discuss the future of COVID-19 disease and vaccines for adolescents and children, specifically in light of his perspective on the enrollment of his twin daughters in the Moderna COVID-19 vaccine trial.

Dr. Emad Rizk, CEO and president of analytics company Cotiviti discusses value-based care success, how close provider-payer partnerships can help deliver the right care, and technology available to help make the most of value care models.

As disparities in health care coverage and access have become spotlighted amid the COVID-19 pandemic, health economics and outcomes research (HEOR) may play a significant role in addressing gaps present in disadvantaged communities and the health care system. Dr. Amy Abernethy speaks on recent innovations within HEOR, how the FDA used data in their response to the pandemic, and the current state of the agency amid an ongoing search for a new FDA Commissioner.

Gale Simons-Poole updates us on the Paycheck Protection Program and what small business owners—including dentists and clinicians—need to know about loan forgiveness. Topics include the basics of PPP loan forgiveness, what borrowers need to qualify, common misconceptions about PPP forgiveness, and some of the most common mistakes that borrowers make when applying for PPP loan forgiveness.

Laura E. Riley, MD. Riley is chair of Obstetrics and Gynecology at Weill Cornell Medicine and Obstetrician and Gynecologist-in-Chief at New York-Presbyterian Hospital in New York City. She specializes in obstetric infectious disease and is a member of the American College of Obstetricians and Gynecologists (ACOG) COVID-19 Task Force.

Doron Schneider, VP, Population Health Services at Tandigm Health, joins to discuss how value-based care strategies helped some independent practices survive during the COVID-19 pandemic.

Pharmacy Times interviewed Michael Holden, FRPharmS, FRSPH, associate director of Pharmacy Complete in the United Kingdom, to discuss some of the key differences between the role of the pharmacist in the United Kingdom versus the United States.

Laura Bukavina, MD, MPH, and Justin Dubin, MD, discuss how findings of a recent peer-reviewed study point to a rise in academic urology programs’ engagement on Twitter for marketing purposes. They also discuss their own usage of social media and share advice for medical professionals using social media.

Peter Carlos and assistant Jaycee Leonardo discuss social media and the effects social media can have on practices. After gaining 1.7 million followers on TikTok, they use what they have learned through their own personal experiences with their social media to help practices grow on social media.

Martin VanTrieste joins Deep Dive to dig into Civica’s business and membership model, its suppliers, the progress it has made in dealing with hospital drug shortages and what motivates VanTrieste to work for free!

Dr. George Yoo discusses the advances in telehealth brought on by the COVID-19 pandemic, some specific telehealth services provided by Karmanos Cancer Center, and walks us through what a telehealth visit might look like.

Dr. Jerry Bagel dives into the complex treatment world of psoriasis. He discusses comorbidities associated with the skin disease, as well as treatment advancements and hurdles, using biologics treatments during the COVID-19 pandemic, and more.